Kontakt
Wie einkaufen
Versand
Kaufberater
Mergers & Acquisitions in the Pharmaceutical Industry
An empirical study of acquirers' ability to create shareholder wealth
Englisch
34 b
Bis zu 30 Tage Rückgaberecht
Kunden kauften auch
/
Kalender
33.99
€
/
Broschur
82.99
€
Abnormal returns in stock markets are subject to many studies. In particular, the ability to test on specific industries has received much attention. The number of M&As have increased in the last decade, which also includes M&A deals in the pharmaceutical (pharma) industry, where companies acquire to reach distinctive capabilities to survive in the dynamic and complex business environment. Companies also utilize M&A to increase their ability to create shareholder wealth, though this has shown partially not to be correct. Previous studies conducted, have found rather different results on M&A transactions. This thesis examines the impact on shareholder wealth in pharmaceutical M&As, more precise the study tests the abnormal stock return around the announcement day. The study is conducted with a data sample consisting of 250 deals in the pharma industry between 2000 and 2014.
Informationen zum Buch
Englisch
Verschenken Sie dieses Buch noch heute
Es ist ganz einfach
1 Legen Sie das Buch in Ihren Warenkorb und wählen Sie den Versand als Geschenk 2 Wir schicken Ihnen umgehend einen Gutschein 3 Das Buch wird an die Adresse des beschenkten Empfängers geliefertDas könnte Sie auch interessieren
/
Broschur
21.09
€
/
Broschur
15.39
€
